Article
Alzheimer Gene BIN1 may Simultaneously Influence Dementia Risk and Androgen Deprivation Therapy Dosage in Prostate Cancer.
American journal of clinical oncology - 1 Oct 2020
Lehrer Steven, Rheinstein Peter H
Abstract excerpt
BACKGROUND: Androgen deprivation therapy (ADT) is extensively used in prostate cancer. Yet the risk of impaired cognition or Alzheimer disease (AD) in men with prostate cancer receiving ADT is uncertain. Some studies of prostate cancer and ADT suggest that the risk of AD is not increased. But other studies have found an increased risk of AD and cognitive impairment. OBJECTIVES: As the uncertainty about ADT and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
